Raju Ajay 4

What Happened
Raju Ajay, a director of Medicus Pharma Ltd. (MDCX), received a grant/award of 25,000 shares classified as a derivative transaction on 2026-03-30. The Form 4 reports the shares at $0.00 per share (transaction coded "A" for award/grant), so no cash was paid; the filing was submitted on 2026-04-01.

Key Details

• Transaction date: 2026-03-30; Form 4 filed: 2026-04-01 (Accession 0000950142-26-001031)
• Transaction type/code: Award/Grant (derivative), code A
• Shares granted: 25,000; reported price per share: $0.00; reported transaction value: $0
• Shares owned after transaction: Not specified in the filing
• Footnotes/conditions: None disclosed in the filing (vesting schedule or conversion terms not provided)
• Timeliness: Filing date is 2026-04-01; the Form 4 does not indicate a late filing

Context
An "A" (award/grant) derivative transaction typically reflects a compensation award such as restricted shares or RSUs that may vest over time; it is not an open-market purchase. Such grants align insiders with shareholder interests but do not necessarily indicate a personal cash investment or a direct market sentiment signal. Retail investors should note vesting and conversion terms (if disclosed later) to assess when the shares become tradeable.